• Own and define the long-term portfolio strategy for Hip enabling technologies, shaping platform evolution, investment priorities, and competitive positioning. • Serve as the upstream marketing lead for the Hip portfolio, guiding strategy from early concept through lifecycle management and portfolio optimization. • Lead the NPDP process end-to-end, partnering closely with R&D, Medical, Regulatory, Finance, Operations, and Sales to drive disciplined, on-time execution. • Translate voice of customer, surgeon insights, and patient needs into clear value propositions and differentiated portfolio strategies. • Act as a strategic partner to key opinion leaders and thought leaders, leveraging insights to inform pipeline direction and platform decisions. • Analyze market dynamics, competitive landscapes, and unmet needs to identify growth opportunities and inform long-range portfolio planning. • Drive portfolio-level decision making, including category definition, segmentation strategy, lifecycle planning, and capital prioritization. • Communicate and influence long-term Hip portfolio strategy across senior leadership to ensure organizational alignment and execution clarity. • Partner with R&D to anticipate future clinical, technological, and competitive needs, ensuring the portfolio remains differentiated and sustainable. • Establish and elevate best practices for portfolio strategy, forecasting, and business performance analysis within the Joint Replacement organization.